Back to Research Hub
Regeneron Pharmaceuticals, Inc.
REGN
$616.18+4.84 (+0.79%)
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic…
StreetsValue research for Regeneron Pharmaceuticals, Inc. (REGN)
Members get the full report for Regeneron Pharmaceuticals, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.